- Home
- AGIO vs RPD Comparison
AGIO vs RPD Comparison
Compare AGIO & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- RPD
- Stock Information
- Founded
- AGIO 2007
- RPD 2000
- Country
- AGIO United States
- RPD United States
- Employees
- AGIO N/A
- RPD N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- RPD Computer Software: Prepackaged Software
- Sector
- AGIO Health Care
- RPD Technology
- Exchange
- AGIO Nasdaq
- RPD Nasdaq
- Market Cap
- AGIO 2.0B
- RPD 2.4B
- IPO Year
- AGIO 2013
- RPD 2015
- Fundamental
- Price
- AGIO $33.23
- RPD $39.54
- Analyst Decision
- AGIO Buy
- RPD Buy
- Analyst Count
- AGIO 7
- RPD 18
- Target Price
- AGIO $56.33
- RPD $44.76
- AVG Volume (30 Days)
- AGIO 975.9K
- RPD 582.8K
- Earning Date
- AGIO 02-13-2025
- RPD 02-12-2025
- Dividend Yield
- AGIO N/A
- RPD N/A
- EPS Growth
- AGIO N/A
- RPD N/A
- EPS
- AGIO 11.80
- RPD 0.66
- Revenue
- AGIO $32,871,000.00
- RPD $833,014,000.00
- Revenue This Year
- AGIO $33.41
- RPD $9.10
- Revenue Next Year
- AGIO $172.14
- RPD $5.35
- P/E Ratio
- AGIO $2.78
- RPD $60.09
- Revenue Growth
- AGIO 36.79
- RPD 10.05
- 52 Week Low
- AGIO $21.18
- RPD $32.95
- 52 Week High
- AGIO $62.58
- RPD $61.88
- Technical
- Relative Strength Index (RSI)
- AGIO 36.88
- RPD 47.58
- Support Level
- AGIO $31.39
- RPD $38.67
- Resistance Level
- AGIO $35.03
- RPD $40.42
- Average True Range (ATR)
- AGIO 1.71
- RPD 1.17
- MACD
- AGIO 0.54
- RPD 0.03
- Stochastic Oscillator
- AGIO 39.91
- RPD 51.71
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.